Skip to main content
Premium Trial:

Request an Annual Quote

Nextval Gets Phase II SBIR Grant for Screening System

NEW YORK (GenomeWeb News) – Nextval has received a $500,000 Phase II SBIR grant from the National Science Foundation to support further development and commercialization of its high-throughput screening system that employs mass spectrometry imaging and microarrays.

The Encinitas, Calif.-based firm said the system is a "novel integration of a nanoliter volume acoustic dispense device with chip-based mass spectrometry." It produces high-density arrays that are analyzed with mass spec imaging and computational algorithms to rapidly screen chemical libraries for high-value molecules, the firm said. It also doesn't require sample labeling.

Nextval said its phase II efforts are focused on a screening product for cellulose enzyme discovery, an enzyme used for production of alternative fuels.

The technology also may be applied to discovery of new enzymes and molecules for the industrial, environmental, pharmaceutical, and diagnostic markets, said Nextval.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.